Private Equity
Strategic Healthcare Investment Partners has set out to raise a $125 million venture-capital fund, according to a filing with the SEC.
1 min read · 08 August 2018
1 min read · 08 August 2018
DNAlite Therapeutics Inc, an gastrointestinal gene therapy biotech startup, has raised $1.5 million in seed financing. Berkeley Catalyst Fund led the round with participation from University of California Berkeley, Blue Bear Ventures, SOSV, the Baldota family, BrightGene and SVE Capital.
1 min read · 08 August 2018
Pivotal bioVenture Partners, a life sciences venture firm, has appointed Dr. Heather Preston as a managing partner. Previously, Preston worked at TPG Biotech where she was a firm partner and managing director. Pivotal is backed by the Nan Fung Group.
3 min read · 08 August 2018
CureGenetics, a biotechnology company focused on developing medicines and molecular diagnostics using gene editing technologies, has secured $17 million in Series A financing. Qiming Venture Partners led the round.
1 min read · 07 August 2018
Benhamou Global Ventures, a Silicon Valley-based early-stage venture firm, has closed its opportunity fund at over $40 million. The fund's investors include previous limited partners and several new international and institutional limited partners.
3 min read · 07 August 2018
AlayaCare, a cloud-based software for home and community care providers, has raised $13.8 million in Series B funding. Inovia Capital led the round with participation from other investors that included Chrysalis.
1 min read · 07 August 2018
OS Fund is raising $250 million for its second fund. OS Fund invests in "entrepreneurs and companies that develop breakthrough discoveries in science to address our most pressing global problems."
4 min read · 07 August 2018
ClearSky has raised $244.7 million of a targeted $300 million for its first security fund, according to a regulatory filing. The venture and growth equity firm has offices in Florida, New York, Boston and San Francisco, and is led by Alexander Weiss, Jay Leek, James Huff, James Goldinger, and Peter Kuper.
1 min read · 07 August 2018
3 min read · 07 August 2018